Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Control of moderate or severe asthma with different doses of ciclesonide
2011-000683-99Phase 4Completed
- Sponsor
- Takeda
- Start
- Jun 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ciclesonide in asthma and severe asthma (3 arms), sponsored by Takeda. Primary endpoint: Asthma control (ACQ) change 640 vs 160 μg/day. Started Jun 2011; status: completed.
02
Drugs
ciclesonide
03
Conditions
asthmasevere asthma
Beyond the preview
Go deeper on 2011-000683-99.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000683-99.